A Food and Drug Administration panel meeting originally set for Feb. 14 to consider Staar Surgical's premarket approval application for its Visian Toric Implantable Collamer Lens system, designed to treat myopic astigmatism, has been rescheduled for next week. The company also won regulatory approval in Japan for an advanced version of the device, which features the CentraFLOW technology.

Related Summaries